GlassScriptPhysician profile
John Roehrs
NPI 1780657668
$1,687.66
in general payments reported to CMS, 2019-2025
9 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,235 · 2021: $13.54 · 2023: $180 · 2024: $31.03 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,216.83 | 2020 | |
| Pulmonx Corporation | $201.35 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $77.28 | 2023 | Fasenra |
| Insmed, INC. | $52.81 | 2023 | |
| Electromed, INC. | $43.19 | 2023-2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $33.22 | 2023 | Nuzyra |
| Fisher & Paykel Healthcare INC | $31.03 | 2024 | Fisher & Paykel Healthcare |
| Jazz Pharmaceuticals INC. | $18.41 | 2020 | |
| Apria Healthcare LLC | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roehrs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.